Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take “several years.”
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec.